Abstract

BackgroundDiagnosing pediatric pneumonia is challenging in low-resource settings. The World Health Organization (WHO) has defined primary end-point radiological pneumonia for use in epidemiological and vaccine studies. However, radiography requires expertise and is often inaccessible. We hypothesized that plasma biomarkers of inflammation and endothelial activation may be useful surrogates for end-point pneumonia, and may provide insight into its biological significance.MethodsWe studied children with WHO-defined clinical pneumonia (n = 155) within a prospective cohort of 1,005 consecutive febrile children presenting to Tanzanian outpatient clinics. Based on x-ray findings, participants were categorized as primary end-point pneumonia (n = 30), other infiltrates (n = 31), or normal chest x-ray (n = 94). Plasma levels of 7 host response biomarkers at presentation were measured by ELISA. Associations between biomarker levels and radiological findings were assessed by Kruskal-Wallis test and multivariable logistic regression. Biomarker ability to predict radiological findings was evaluated using receiver operating characteristic curve analysis and Classification and Regression Tree analysis.ResultsCompared to children with normal x-ray, children with end-point pneumonia had significantly higher C-reactive protein, procalcitonin and Chitinase 3-like-1, while those with other infiltrates had elevated procalcitonin and von Willebrand Factor and decreased soluble Tie-2 and endoglin. Clinical variables were not predictive of radiological findings. Classification and Regression Tree analysis generated multi-marker models with improved performance over single markers for discriminating between groups. A model based on C-reactive protein and Chitinase 3-like-1 discriminated between end-point pneumonia and non-end-point pneumonia with 93.3% sensitivity (95% confidence interval 76.5–98.8), 80.8% specificity (72.6–87.1), positive likelihood ratio 4.9 (3.4–7.1), negative likelihood ratio 0.083 (0.022–0.32), and misclassification rate 0.20 (standard error 0.038).ConclusionsIn Tanzanian children with WHO-defined clinical pneumonia, combinations of host biomarkers distinguished between end-point pneumonia, other infiltrates, and normal chest x-ray, whereas clinical variables did not. These findings generate pathophysiological hypotheses and may have potential research and clinical utility.

Highlights

  • Pneumonia causes an estimated 1.4 million childhood deaths annually [1]

  • We studied children with World Health Organization (WHO)-defined clinical pneumonia (n = 155) within a prospective cohort of 1,005 consecutive febrile children presenting to Tanzanian outpatient clinics

  • Classification and Regression Tree analysis generated multi-marker models with improved performance over single markers for discriminating between groups

Read more

Summary

Introduction

Pneumonia causes an estimated 1.4 million childhood deaths annually [1]. Immunization against Streptococcus pneumoniae and Haemophilus influenzae type B has significantly decreased pneumonia incidence and mortality [2, 3], and vaccine introduction into lowincome countries is ongoing. World Health Organization (WHO) diagnostic criteria used in community settings in lowincome countries–based on cough, tachypnea, and chest indrawing [7]–are poorly suited for research studies. These criteria are highly sensitive, and their implementation decreased childhood pneumonia mortality by 36% [8]; they lack specificity and likely capture many non-pneumonia infections [9]. Chest radiography has been regarded as a practical gold standard It has some caveats: infiltrate patterns do not perfectly discriminate bacterial from viral etiology [11,12,13], nor self-limited infections from those requiring antibiotics [14]. We hypothesized that plasma biomarkers of inflammation and endothelial activation may be useful surrogates for end-point pneumonia, and may provide insight into its biological significance

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call